165 related articles for article (PubMed ID: 32163392)
1. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression].
Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T
Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
3. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
[TBL] [Abstract][Full Text] [Related]
5. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
6. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
7. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
[TBL] [Abstract][Full Text] [Related]
8. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.
Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM
J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799
[TBL] [Abstract][Full Text] [Related]
9. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
10. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
[TBL] [Abstract][Full Text] [Related]
11. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
Hou H; Sun H; Lu P; Ge C; Zhang L; Li H; Zhao F; Tian H; Zhang L; Chen T; Yao M; Li J
Mol Cancer Ther; 2013 Dec; 12(12):2874-84. PubMed ID: 24130050
[TBL] [Abstract][Full Text] [Related]
12. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
[TBL] [Abstract][Full Text] [Related]
13. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
Jiang G; Wen L; Deng W; Jian Z; Zheng H
Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
[TBL] [Abstract][Full Text] [Related]
15. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
Jia Q; Zhang X; Deng T; Gao J
Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
[TBL] [Abstract][Full Text] [Related]
17. Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma.
Sukowati CH; Rosso N; Pascut D; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C
BMC Gastroenterol; 2012 Nov; 12():160. PubMed ID: 23153066
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1.
Xiang L; Huang X; Wang S; Ou H; Chen Z; Hu Z; Huang Y; Li X; Yuan Y; Yang D
Cancer Sci; 2020 Nov; 111(11):4102-4117. PubMed ID: 32808348
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
20. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
